Engineers at Rose-Hulman Ventures are working with surgeons and pathologists at the Indiana University School of Medicine on a biospy tool that may save lives by reducing how long it takes to detect skin cancer. The device involves using suction through a vacuum tube to produce uniform tissue depth for biopsies. At present, the inability… Read more »
Tag: IU School of Medicine
IU ranked among world's 50 most innovative universities, based on patent, publishing data
According to a Reuters News analysis of patent and publishing data from hundreds of research institutions around the globe between 2008 and 2013, Indiana University ranks among the world’s 50 most innovative universities. IU placed 49th in the list of Top 100 World’s Most Innovative Universities and 33rd among U.S. universities. Twelve of the Top 100, including… Read more »
New institute at IUPUI focused on making Indy an innovative, entrepreneurial hub for sports
What can Twitter posts tell sports marketers, product developers and budding entrepreneurs? For now, it’s hard to know — but the newly launched Sports Innovation Institute at IUPUI aims to find out. By bridging the gap between academia and the sports industry, the institute will help both sectors gain deeper insight into the impact that… Read more »
Five finalist proposals announced for IU's Grand Challenges research program
The most ambitious research effort in Indiana University history — the Grand Challenges program — announced five finalists on Thursday (Jan. 8) to submit full proposals for consideration by an April 18 deadline. Over the next four months, IU’s Office of the Vice President for Research and other university entities will work with finalist teams… Read more »
Article details IURTC's efforts to help bring an IU researcher's antibiotic derivative to market
Back in mid-2015, the Indiana University Research and Technology Corp. struck a deal with California-based La Jolla Pharmaceutical Co. to acquire intellectual property rights to “next-generation” offshoots of gentamicin — a hospital-grade antibiotic which has limited use because of its toxicity. Because the offshoots have shown signs of lacking such toxicity, they hold promise in… Read more »
Sideline diagnosis of concussions is the goal of two researchers at IU's School of Optometry
In a November 22 NFL game between the St. Louis Rams and the Baltimore Ravens, Rams quarterback Case Keenum was sacked in the fourth quarter and hit his head on the turf. Despite the Rams sending their head trainer on the field to talk with Keenum — and the presence of an NFL injury… Read more »
Former IUSM researcher, administrator Wilkes receives IU President's Medal for Excellence
Dr. David Wilkes, who recently became dean of the University of Virginia School of Medicine after serving as former associate vice president for research and executive associate dean for research affairs at Indiana University School of Medicine, is one of the latest recipients of the President’s Medal of Excellence at IU. The President’s Medal is… Read more »
DiMarchi to keynote, Kelley to be honored at Innovation to Enterprise event set for Nov. 4
One of Indiana University’s most distinguished researchers, Richard DiMarchi, will serve as keynote speaker for the IUPUI Innovation to Enterprise Forum & Showcase set for Wednesday, Nov. 4 at the IUPUI Campus Center Theater. The event highlights the research and creative successes of IU faculty, scientists and students, which will be featured during a showcase… Read more »
Auricyte wins Best Pre-Venture category at BioCrossroads New Venture competition, while Arrhythotech places second overall
Auricyte LLC, launched by three Indiana University scientists to cure hearing loss by turning human stem cells into hearing cells, won the Best Pre-Venture category Wednesday (Oct. 14) at the BioCrossroads New Venture Competition. The victory marks the third time in four years that a product of IU’s Spin Up program, created by the Indiana… Read more »
IU-related startups comprise half the finalists for BioCrossroads New Venture Competition
Half of the six finalists for this year’s BioCrossroads New Venture Competition announced Monday have ties to Indiana University. The contest, now in its fourth year, recognizes some of Indiana’s best up-and-coming life sciences companies and has awarded more than $180,000 to a dozen startups since its 2012 inception. Finalists linked to IU include: Arrhythmotech:… Read more »